Disease-Based Health Outcomes Indices
Health Policy Research Reports
Global Health Consulting

Disease-Based Health Outcomes Indices

GHO develops innovative health information products specifically tailored to the modern and emerging needs of the health care industry.  GHO’s core product – disease-based health outcomes indices (HOIs) – are derived from our Health Outcomes Indices portfolio and are scheduled for launch in the second quarter of 2010.  Disease-based HOIs measure and forecast health outcomes at the population-level to reflect the health care industry’s fundamental activity, by measuring, analyzing and organizing outcomes data by particular diseases.

Based on our novel and proprietary methods, GHO will measure the current and future burden of various chronic diseases.  Each HOI is based upon real-world data related to clinical, economic and humanistic health outcomes.  Each HOI undergoes an extensive pre-publication evaluation and analysis, incorporating expert clinical input and independent validation.  Furthermore, each HOI is stratified by a particular sub-population, such as by geography, age, insurance coverage and ethnicity. 

Once published, each HOI will be frequently updated to capture the relative health gain or burden of a particular disease over time, thus reflecting current and emerging trends in outcomes research and disease management.  As part of this updating process, each HOI will be subject to a rigorous re-validation process to ensure that the HOI continues to be a robust measurement.  As a result of continuous testing and validation, GHO’s disease-based HOIs are superior to current health outcomes measurements.

A diverse spectrum of participants in the health care industry will benefit from disease-based HOIs.  Stakeholders include government healthcare programs, managed care organizations, life sciences, patient advocacy groups and the life insurance industry.  Each of these stakeholders will benefit from a mechanism that can accurately gauge the health of populations and provide a tool for cost-benefit analysis of new and existing treatment options. Subscribers will be able to gauge trends in changing health status for these chronic diseases and adjust their business and investment plans by using comparative effectiveness and analytical tools to meet the needs of their specific patient populations.

The first set of disease-based HOIs will focus on Diabetes, a market that includes approximately 28 million patients and annual investments of over $116 billion.  For additional information, please review the attached sample analyses that would be provided along with a subscription to our Diabetes Health Outcomes Index reports. 

Health Policy Research Reports

In addition to its HOI portfolio, GHO provides frequent health policy research reports.  Based upon objective and data-driven metrics, GHO’s health policy research reports examine current and emerging issues in health policy from a unique perspective, synthesizing our expertise in government policy, life sciences, intellectual property, bioinformatics and investment analysis.  By examining the short-term and long-term effects of health policy initiatives through various lenses, GHO’s health policy research reports dig beyond the headlines and serve as a valuable tool for the investment community.  A sampling of past reports is available on our Download Publications page. 

Global Health Consulting

Through its consulting services, GHO promotes and guides its customers in the creation and application of evidence-based health outcomes and innovative comparative effectiveness research methods.  A novel and proprietary method to health outcomes research is what distinguishes GHO consulting from its competitors.  GHO consulting is able to capitalize on its unique position in the health outcomes and comparative effectiveness space, thus providing its customers with timely and accurate health-related information that can be utilized to influence federal and state policy, payment decisions, risk management and investments.  GHO’s consulting services include conducting market research, business plan development, product feasibility analysis, population-based outcomes analysis, marketing and business plan strategy, sales force development, customer relationship management and public relations.